Avitinib
Avitinib (AC0010) is an orally bioavailable, irreversible inhibitor that selectively targets mutant epidermal growth factor receptor (EGFR), including the T790M resistance mutation. It is used in oncology research to study tumor growth inhibition in EGFR-mutated models, with applications in both in vitro cellular assays and in vivo xenograft experiments.
Product Specifications
CAS Number
1557267-42-1
Product Name Alternative
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.81% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.77 mM) ; DMSO:88 mg/mL (180.5 mM)
Smiles
CN1CCN (CC1) c1ccc (Nc2nc (Oc3cccc (NC (=O) C=C) c3) c3cc[nH]c3n2) cc1F
Molecular Formula
C26H26FN7O2
Molecular Weight
487.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
C-C Motif Chemokine 27 (CCL27) BioAssayTM ELISA Kit (Human) (ALP, CTACK, CTAK, ESKINE, ILC, PESKY, SCYA27, CC chemokine ILC, IL-11 R alpha-locus chemokine, Cutaneous T-cell attracting chemokine, Skinkine, Small inducible cytokine A27)
C-C Motif Chemokine 27 (CCL27) BioAssayTM ELISA Kit (Human) (ALP, CTACK, CTAK, ESKINE, ILC, PESKY, SCYA27, CC chemokine ILC, IL-11 R alpha-locus chemokine, Cutaneous T-cell attracting chemokine, Skinkine, Small inducible cytokine A27)
Mouse Myelin protein zero-like protein 2, MPZL2 ELISA Kit